PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.32%
Revenue growth at 75-90% of META's 3.75%. Bill Ackman would push for innovation or market expansion to catch up.
3.65%
Gross profit growth 1.25-1.5x META's 2.65%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
183.25%
Positive EBIT growth while META is negative. John Neff might see a substantial edge in operational management.
183.25%
Positive operating income growth while META is negative. John Neff might view this as a competitive edge in operations.
187.70%
Net income growth above 1.5x META's 0.61%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
186.96%
EPS growth above 1.5x META's 1.14%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
182.61%
Diluted EPS growth above 1.5x META's 1.15%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.18%
Slight or no buybacks while META is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.09%
Slight or no buyback while META is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
30.38%
OCF growth above 1.5x META's 19.00%. David Dodd would confirm a clear edge in underlying cash generation.
70.31%
FCF growth above 1.5x META's 46.23%. David Dodd would verify if the firm’s strategic investments yield superior returns.
449.94%
10Y revenue/share CAGR under 50% of META's 1113.15%. Michael Burry would suspect a lasting competitive disadvantage.
117.24%
5Y revenue/share CAGR under 50% of META's 486.74%. Michael Burry would suspect a significant competitive gap or product weakness.
78.12%
3Y revenue/share CAGR under 50% of META's 198.07%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
446.07%
10Y OCF/share CAGR under 50% of META's 1018.59%. Michael Burry would worry about a persistent underperformance in cash creation.
149.20%
Below 50% of META's 579.93%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
116.81%
3Y OCF/share CAGR under 50% of META's 234.23%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
543.62%
Below 50% of META's 1807.97%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
196.77%
Below 50% of META's 948.96%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
127.76%
Below 50% of META's 463.49%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
458.33%
Equity/share CAGR of 458.33% while META is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
96.24%
Below 50% of META's 430.59%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
44.05%
Below 50% of META's 89.58%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.77%
AR growth well above META's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
73.64%
Inventory growth of 73.64% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.69%
Asset growth above 1.5x META's 2.39%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.65%
BV/share growth above 1.5x META's 1.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.13%
We have some new debt while META reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.31%
R&D dropping or stable vs. META's 5.31%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.33%
SG&A declining or stable vs. META's 9.12%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.